Skip to main content
Log in

Morbus Osler

Osler’s disease

  • Leitthema
  • Published:
Der Radiologe Aims and scope Submit manuscript

Zusammenfassung

Der Mobus Osler (Synonyme: hereditäre hämorrhagische Teleangiektasie [HHT], Morbus Rendu-Osler-Weber) ist eine Multisystemerkrankung und gehört zur Gruppe der vaskulären hämorrhagischen Erkrankungen. Bei der autosomal dominanten Erkrankung, die zu den häufigsten Phakomatosen zählt, kann je nach Gendefekt zwischen verschiedenen Formen, die zu einer Störung der Blutgefäßbildung führen, unterschieden werden. Neben der genetischen Diagnostik und der klinischen Untersuchung sind bildgebende Verfahren entscheidend für die Diagnose. Klinisch stehen die Epistaxis, mukokutane Teleangiektasien und viszerale arteriovenöse Malformationen (AVM) v. a. in Lunge, Leber und Hirn sowie die Folgen dieser Gefäßpathologien wie z. B. intrakranielle Abszesse und Hirninfarkte im Vordergrund. Sie können mit der modernen Bildgebung magnetresonanz- und computertomographisch nachgewiesen werden. Pulmonale AVM können häufig computertomographisch auch ohne Kontrastmittelgabe diagnostiziert werden, wohingegen die anderen viszeralen Manifestationen einschließlich einer etwaigen zentralnervösen Beteiligung in der Regel eine Kontrastmittelgabe in der MRT oder CT erforderlich machen. Kenntnisse über die mögliche Organmanifestation, resultierende Komplikationen und die typischen radiologischen Befunde sind entscheidend für die adäquate Behandlung der betroffenen Patienten. Die interventionelle Radiologie/Neuroradiologie spielt auch zunehmend eine wichtige Rolle bei der Behandlung von HHT-Patienten.

Abstract

Osler’s disease, also known as hereditary hemorrhagic telangiectasia (HHT) and Osler-Weber-Rendu syndrome, is an autosomal dominant disorder leading to abnormal blood vessel formation in the skin, mucous membranes and often in organs, such as the lungs, liver and brain (arteriovenous malformations AVM). Various types are known. Patients may present with epistaxis. Teleangiectasia can be identified by visual inspection during physical examination of the skin or oral cavity or by endoscopy. Diagnosis is made after clinical examination and genetic testing based on the Curacao criteria. Modern imaging modalities, such as computed tomography (CT) or magnetic resonance imaging (MRI) have become more important as they can depict the AVMs. Pulmonary AVMs can be depicted in CT imaging even without the use of a contrast agent while other locations including the central nervous system (CNS) usually require administration of contrast agents. Knowledge of possible clinical manifestations in various organs, possible complications and typical radiological presentation is mandatory to enable adequate therapy of these patients. Interventional procedures are becoming increasingly more important in the treatment of HHT patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Braverman IM, Keh A, Jacobson BS (1990) Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia. J Invest Dermatol 95(4):422–427

    Article  PubMed  CAS  Google Scholar 

  2. Buscarini E, Buscarini L, Danesino C et al (1997) Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Doppler sonographic screening in a large family. J Hepatol 26:111–118

    Article  PubMed  CAS  Google Scholar 

  3. Carette MF, Brugieres P, Khalil A (2007) Hyperintense basal ganglia on T1-weighted images in Rendu-Osler-Weber disease. Presse Med 36:883–884

    Article  PubMed  Google Scholar 

  4. Carette MF, Nedelcu C, Tassart M et al (2009) Imaging of hereditary hemorrhagic telangiectasia. Cardiovasc Intervent Radiol 32(4):745–757. doi:10.1007/s00270-008-9344-2

    Article  PubMed  PubMed Central  Google Scholar 

  5. Cottin V, Chinet T, Lavolé A et al (2007) Pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: a series of 126 patients. Medicine (Baltimore) 86:1–17

    Google Scholar 

  6. Easey AJ, Wallace GM, Hughes JM et al (2003) Should asymptomatic patients with hereditary haemorrhagic telangiectasia (HHT) be screened for cerebral vascular malformations? Data from 22,061 years of HHT patient life. J Neurol Neurosurg Psychiatry 74:743–748

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  7. Fulbright RK, Chaloupka JC, Putman CM et al (1998) MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations. AJNR Am J Neuroradiol 19:477–484

    PubMed  CAS  Google Scholar 

  8. Garcia-Monaco R, Taylor W, Rodesch G et al (1995) Pial arteriovenous fistula in children as presenting manifestation of Rendu-Osler-Weber disease. Neuroradiology 37:60–64

    Article  PubMed  CAS  Google Scholar 

  9. Graf CJ, Perret GE, Torner JC (1983) Bleeding from cerebral arteriovenous malformations as part of their natural history. J Neurosurg 58:331–337

    Article  PubMed  CAS  Google Scholar 

  10. Ianora AA, Memeo M, Sabba C et al (2004) Hereditary hemorrhagic telangiectasia: multi – detector row helical CT assessment of hepatic involvement. Radiology 230:250–259

    Article  PubMed  Google Scholar 

  11. Jaskolka J, Wu L, Chan RP, Faughnan ME (2003) Imaging of hereditary hemorrhagic telangiectasia. AJR Am J Roentgenol 183:307–314

    Article  Google Scholar 

  12. Khalil A, Farres MT, Mangiapan G et al (2000) Pulmonary arteriovenous malformations. Chest 117:1399–1403

    Article  PubMed  CAS  Google Scholar 

  13. Kim TK, Choi BI, Han JK et al (1998) Nontumorous arterioportal shunt mimicking hypervascular tumor in cirrhotic liver: twophase spiral CT findings. Radiology 208:597–603

    PubMed  CAS  Google Scholar 

  14. Krings T, Chng SM, Ozanne A et al (2005) Hereditary haemorrhagic telangiectasia in children. endovascular treatment of neurovascular malformations results in 31 patients interventional. Neuroradiology 11:13–23

    CAS  Google Scholar 

  15. Lesca G, Olivieri C, Burnichon N et al (2007) Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network. Genet Med 9:14–22

    Article  PubMed  Google Scholar 

  16. Maarouf M, Runge M, Kocher M et al (2004) Radiosurgery for cerebral arteriovenous malformations in hereditary hemorrhagic telangiectasia. Neurology 63:367–369

    Article  PubMed  CAS  Google Scholar 

  17. Maher CO, Piepgras DG, Brown RD Jr et al (2001) Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia. Stroke 32:877–882

    Article  PubMed  CAS  Google Scholar 

  18. Memeo M, Stabile Ianora AA, Scardapane A et al (2004) Hepatic involvement in hereditary hemorrhagic telangiectasia: CT findings. Abdom Imaging 29:211–220

    Article  PubMed  CAS  Google Scholar 

  19. Nanthakumar K, Graham AT, Robinson TI et al (2001) Contrast echocardiography for detection of pulmonary arteriovenous malformations. Am Heart J 141:243–246

    Article  PubMed  CAS  Google Scholar 

  20. Oliver JH 3rd, Baron RL (1996) Helical biphasic contrast-enhanced CT of the liver: technique, indications, interpretation, and pitfalls. Radiology 201:1–14

    PubMed  Google Scholar 

  21. Remy-Jardin M, Dumont P, Brillet PY et al (2006) Pulmonary arteriovenous malformations treated with embolotherapy: helical CT evaluation of long-term effectiveness after 2–21-year follow-up. Radiology 239:576–585

    Article  PubMed  Google Scholar 

  22. Remy J, Remy-Jardin M, Wattinne L, Deffontaines C (1992) Pulmonary arteriovenous malformations: evaluation with CT of the chest before and after treatment. Radiology 182:809–816

    PubMed  CAS  Google Scholar 

  23. Siddiki H, Doherty MG, Fletcher JG et al (2008) Abdominal findings in hereditary hemorrhagic telangiectasia: pictorial essay on 2D and 3D findings with isotropic multiphase CT. Radiographics 28(1):171–184. doi:10.1148/rg.281075037

    Article  PubMed  Google Scholar 

  24. Weber MA, Ahlhelm F, Essig M et al (2007) Treatment options for arteriovenous malformations. Radiologe 47(10):893–899

    Article  PubMed  Google Scholar 

  25. Werner JA, Lippert BM, Geisthoff UW, Rudert H (1997) Nd:YAG laser therapy of recurrent epistaxis in hereditary hemorrhagic telangiectasia. Laryngorhinootologie 76(8):495–501

    Article  PubMed  CAS  Google Scholar 

  26. White RI Jr, Lynch-Nyhan A, Terry P et al (1988) Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy. Radiology 169:663–669

    PubMed  Google Scholar 

  27. White RI Jr, Pollack JS, Wirth JA (1996) Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy. J Vasc Interv Radiol 7:787–804

    Article  PubMed  Google Scholar 

  28. Yu JS, Kim KW, Sung KB et al (1997) Small arterial-portal venous shunts: a cause of pseudolesions at hepatic imaging. Radiology 203:737–742

    PubMed  CAS  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. F. Ahlhelm, J. Lieb, G. Schneider, U. Müller, S. Ulmer geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F. Ahlhelm.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ahlhelm, F., Lieb, J., Schneider, G. et al. Morbus Osler. Radiologe 53, 1084–1090 (2013). https://doi.org/10.1007/s00117-013-2552-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00117-013-2552-z

Schlüsselwörter

Keywords

Navigation